Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 4862016, 11 pages
https://doi.org/10.1155/2017/4862016
Research Article

Expression of AdipoR1 and AdipoR2 Receptors as Leptin-Breast Cancer Regulation Mechanisms

1Faculty of Chemistry, Autonomous University of the State of Mexico (UAEMex), Toluca, MEX, Mexico
2Specialized Hemato-Oncological Laboratory of the Children’s Hospital, IMIEM, Toluca, MEX, Mexico
3Molecular Biology Laboratory, Medical Research Center (CICMED), Toluca, MEX, Mexico
4Laboratory of Immunohistochemistry, National Pediatrics Institute, Coyoacán, MEX, Mexico

Correspondence should be addressed to Jonnathan Guadalupe Santillán-Benítez; xm.moc.oohay@bsgnahtannoj

Received 24 May 2017; Accepted 20 July 2017; Published 5 September 2017

Academic Editor: Stefano M. M. Basso

Copyright © 2017 Martha Daniela Mociño-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Jardé, F. Caldefie-Chézet, M. Damez et al., “Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma,” Oncology Reports, vol. 19, pp. 905–911, 2008. View at Google Scholar
  2. L. M. Morimoto, E. White, Z. Chen et al., “Obesity, body size, and risk of postmenopausal breast cancer: the women’s health initiative (United States),” Cancer Causes and Control, vol. 13, pp. 741–751, 2002. View at Google Scholar
  3. M. J. Khandekar, P. Cohen, and B. M. Spiegelman, “Molecular mechanisms of cancer development in obesity,” Nature Reviews, vol. 11, pp. 886–895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Jardé, S. Perrier, M. P. Vasson, and F. Caldefie-Chézet, “Molecular mechanisms of leptin and adiponectin in breast cancer,” European Journal of Cancer, vol. 47, pp. 33–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. E. Ruhl and J. E. Everhart, “Leptin concentrations in the United States: relations with demographic and anthropometric measures,” The American Journal of Clinical Nutrition, vol. 74, pp. 295–301, 2001. View at Google Scholar
  6. H. S. Moon, M. Dalamaga, S. Y. Kim et al., “Leptin’s role in lipodystrophic and nonlipodystrophic insulin resistant and diabetic individuals,” Endocrine Reviews, vol. 34, pp. 377–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Dalamaga, S. H. Chou, K. Shields, P. Papageorgiou, S. A. Polyzos, and C. S. Mantzoros, “Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives,” Cell Metabolism, vol. 18, pp. 29–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Housa, J. Housová, Z. Vernerová, and M. Haluzík, “Adipocytokines and cancer,” Physiological Research, vol. 55, pp. 233–244, 2006. View at Google Scholar
  9. L. Delort, T. Jardé, V. Dubois, M. P. Vasson, and F. Caldefie-Chézet, “New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer?” Vitamins and Hormones, vol. 90, pp. 397–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura, “Adiponectin and metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, pp. 29–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. López Fontana, M. E. Maselli Artola, N. Di Milta Mónaco et al., “Influencia de la leptina y la adiponectina sobre el cáncer de próstata,” Archivos Españoles de Urología, vol. 62, no. 2, pp. 103–108, 2009. View at Google Scholar
  12. J. Thundyil, D. Pavlovski, C. G. Sobey, and T. V. Arumugam, “Adiponectin receptor signalling in the brain,” British Journal of Pharmacology, vol. 165, pp. 313–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-H. Lee, R. L. Klein, H. M. El-Shewy, D. K. Luttrell, and L. M. Luttrell, “The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth,” Biochemistry, vol. 47, no. 44, pp. 11682–11692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Chandran, S. A. Phillips, T. Ciaraldi, and R. R. Henry, “Adiponectin: more than just another fat cell hormone?” Diabetes Care, vol. 26, pp. 2442–2450, 2003. View at Google Scholar
  15. A. Fujimoto, S. Akifusa, N. Kamio, T. Hirofuji, K. Nonaka, and Y. Yamashita, “Involvement of mTOR in globular adiponectin-induced generation of reactive oxygen species,” Free Radical Research, vol. 44, pp. 128–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Google Scholar
  17. R. Fusco, M. Galgani, C. Procaccini et al., “Cellular and molecular crosstalk between leptin receptor and estrogen receptor- {alpha} in breast cancer: molecular basis for a novel therapeutic setting,” Endocrine-Related Cancer, vol. 17, no. 2, pp. 373–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. A. Frankenberry, H. Skinner, P. Somasundar, D. W. McFadden, and L. C. Vona-Davis, “Leptin receptor expression and cell signaling in breast cancer,” International Journal of Oncology, vol. 28, no. 4, pp. 985–993, 2006. View at Google Scholar
  19. K. J. Nkhata, A. Ray, T. F. Schuster, M. E. Grossmann, and M. P. Cleary, “Effects of adiponectin and leptin co-treatment on human breast cancer cell growth,” Oncology Reports, vol. 21, no. 6, pp. 1611–1619, 2009. View at Google Scholar
  20. C. Garofalo, D. Sisci, and E. Surmacz, “Leptin interferes with the effects of the antiestrogen ICI 182, 780 in MCF-7 breast cancer cells,” Clinical Cancer Research, vol. 10, no. 19, pp. 6466–6475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Yin, D. Wang, H. Zhang et al., “Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin,” Cancer Research, vol. 64, pp. 5870–5875, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. G. Santillan Benitez, A. Ordoñez, Z. H. Mendieta, and L. M. Gómez Oliván, “La leptina en la carcinogénesis mamaria. Vías de señalización,” Química Viva, vol. 2, no. 11, pp. 91–111, 2012. View at Google Scholar
  23. M. Okumura, M. Yamamoto, H. Sakuma et al., “Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1592, no. 2, pp. 107–116, 2002. View at Google Scholar
  24. R. R. Gonzalez, S. Cherfils, M. Escobar et al., “Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2),” The Journal of Biological Chemistry, vol. 281, no. 36, pp. 26320–26328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. Binai, A. Damert, G. Carra et al., “Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells,” International Journal of Cancer, vol. 127, no. 1, pp. 55–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Chen, Y. C. Chang, C. L. Liu, K. J. Chang, and I. C. Guo, “Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and downregulation of tumor suppressor p53 and p21WAF1/CIP1,” Breast Cancer Research and Treatment, vol. 98, no. 2, pp. 121–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Jarde, F. Caldefie-Chezet, N. Goncalves-Mendes et al., “Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies,” Endocrine-Related Cancer, vol. 16, no. 4, pp. 1197–1210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. N. Dieudonne, M. Bussiere, E. Dos Santos, M. C. Leneveu, Y. Giudicelli, and R. Pecquery, “Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 271–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Taliaferro-Smith, A. Nagalingam, D. Zhong, W. Zhou, N. K. Saxena, and D. Sharma, “LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells,” Oncogene, vol. 28, no. 29, pp. 2621–2633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Nakayama, Y. Miyoshi, H. Ishihara, and S. Noguchi, “Growth inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis,” Breast Cancer Research and Treatment, vol. 112, no. 3, pp. 405–410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Wang, J. B. Lam, K. S. Lam et al., “Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice,” Cancer Research, vol. 66, no. 23, pp. 11462–11470, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. H. Kang, Y. Y. Lee, B. Y. Yu et al., “Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell,” Archives of Pharmacal Research, vol. 28, no. 11, pp. 1263–1269, 2005. View at Google Scholar
  33. A. Korner, K. Pazaitou-Panayiotou, T. Kelesidis et al., “Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 3, pp. 1041–1048, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. E. Grossmann, K. J. Nkhata, K. MizunoN, A. Ray, and M. P. Cleary, “Effects of adiponectin on breast cancer cell growth and signaling,” British Journal of Cancer, vol. 98, pp. 370–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Dos Santos, D. Benaitreau, M. N. Dieudonne et al., “Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells,” Oncology Reports, vol. 20, no. 4, pp. 971–977, 2008. View at Google Scholar
  36. O. Treeck, C. Lattrich, I. Juhasz-Boess, S. Buchholz, G. Pfeiler, and O. Ortmann, “Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells,” British Journal of Cancer, vol. 99, no. 8, pp. 1246–1250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Soma, J. Kitayama, H. Yamashita, H. Miyato, M. Ishikawa, and H. Nagawa, “Leptin augments proliferation of breast cancer cells via transactivation of HER2,” The Journal of Surgical Research, vol. 149, no. 1, pp. 9–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Somasundar, A. K. Yu, L. Vona-Davis, and D. W. McFadden, “Differential effects of leptin on cancer in vitro,” The Journal of Surgical Research, vol. 113, no. 1, pp. 50–55, 2003. View at Google Scholar
  39. F. J. García Vázquez and J. E. Farfán Morales, “Manual Técnicas de Herramientas en Patología,” Inmunohistoquímica, vol. 1, 2014. View at Google Scholar
  40. V. Dubois, L. Delort, H. Billard, M. P. Vasson, and F. Caldefie-Chezet, “Breast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies?” PLoS One, vol. 3, no. 8, article e58541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta DeltaC(T)) method,” Methods, vol. 25, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, pp. 2003–2007, 2001. View at Google Scholar
  43. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, pp. 1100–1108, 2008. View at Google Scholar
  44. G. E. Tomlinson, T. T. Chen, V. A. Stasny et al., “Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier,” Cancer Research, vol. 58, pp. 3237–3242, 1998. View at Google Scholar
  45. A. M. Lorincz and S. Sukumar, “Molecular links between obesity and breast cancer,” Endocrine-Related Cancer, vol. 13, pp. 279–292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. T. Chlebowski, E. Aiello, and A. McTiernan, “Weight loss in breast cancer patient management,” Journal of Clinical Oncology, vol. 20, no. 4, pp. 1128–1143, 2002. View at Publisher · View at Google Scholar
  47. A. F. Gazdar, V. Kurvari, A. Virmani et al., “Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer,” International Journal of Cancer, vol. 78, pp. 766–774, 1998. View at Google Scholar
  48. M. N. Dieudonne, F. Machinal-Quelin, V. Serazin-Leroy, M. C. Leneveu, R. Pecquery, and Y. Giudicelli, “Leptin mediates a proliferative response in human MCF7 breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 293, no. 1, pp. 622–628, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Naviglio, D. Di Gesto, A. Sorrentino et al., “Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells,” Cancer Biology & Therapy, vol. 8, no. 12, pp. 1183–1190, 2009. View at Google Scholar
  50. T. Tsukada, S. Fushida, S. Harada et al., “Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer,” Journal of Experimental & Clinical Cancer Research, vol. 30, p. 107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Y. Kim, Y. S. Lee, K. H. Kim et al., “Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation,” Molecular Endocrinology, vol. 24, no. 7, pp. 1441–1452, 2010. View at Publisher · View at Google Scholar · View at Scopus